Effects of liraglutide on intracerebral amyloid deposition in Alzheimer's Disease.

Trial Profile

Effects of liraglutide on intracerebral amyloid deposition in Alzheimer's Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2017

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Alzheimer's disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes.
    • 13 Jun 2017 Results of effect of liraglutide in terms of cerebral metabolic rate of glucose (n=38) presented at the 77th Annual Scientific Sessions of the American Diabetes Association
    • 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top